Patient Based Validation and Improvement of the Laboratory Based Calibration of the Fast Dose Calculator for Passive Scattering Proton Therapy at The University of Texas MD Anderson Cancer Center

Adair A.; Wang Q.; Yepes P.; Titt U.; Mirkovic D.; Mohan R.

首页> 外文期刊>Medical Physics >Patient Based Validation and Improvement of the Laboratory Based Calibration of the Fast Dose Calculator for Passive Scattering Proton Therapy at The University of Texas MD Anderson Cancer Center

【24h】

Patient Based Validation and Improvement of the Laboratory Based Calibration of the Fast Dose Calculator for Passive Scattering Proton Therapy at The University of Texas MD Anderson Cancer Center

机译：基于患者基于患者的验证和改进了德克萨斯州和德斯逊大学安德森癌症中心被动散射质子疗法的快速剂量计算器校准

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Medical Physics》 |2018年第6期|共1页
作者
Adair A.; Wang Q.; Yepes P.; Titt U.; Mirkovic D.; Mohan R.;
展开▼
作者单位

Rice Univ Houston TX USA;

Rice Univ Houston TX USA;

Rice Univ Houston TX USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类基础医学;
关键词

相似文献

外文文献
中文文献
专利

1. Patient Based Validation and Improvement of the Laboratory Based Calibration of the Fast Dose Calculator for Passive Scattering Proton Therapy at The University of Texas MD Anderson Cancer Center [J] . Adair A., Wang Q., Yepes P., Medical Physics . 2018,第6期

机译：基于患者基于患者的验证和改进了德克萨斯州和德斯逊大学安德森癌症中心被动散射质子疗法的快速剂量计算器校准
2. Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099. [J] . Alvarez RH, Booser DJ, Cristofanilli M, Cancer: A Journal of the American Cancer Society . 2010,第5期

机译：根据IIB期至III期乳腺癌患者的临床和病理反应，采用阿霉素和多西他赛进行初次全身治疗，然后进行手术，放疗和辅助化疗联合环磷酰胺，甲氨蝶呤和5-氟尿嘧啶的2期临床试验：德克萨斯大学医学博士安德森癌症中心研究ID97-099。
3. An overview of the comprehensive proton therapy machine quality assurance procedures implemented at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center-Houston. [J] . Arjomandy B, Sahoo N, Zhu XR Medical Physics . 2009,第6期

机译：德克萨斯大学安德森分校癌症中心休斯敦质子治疗中心实施的全面质子治疗机质量保证程序的概述。
4. The University of Texas M.D. Anderson Cancer Center Proton Therapy Facility [C] . Alfred Smith, Wayne Newhauser, Mitchell Latinkic, Application of Accelerators in Research and Industry . 2003

机译：德克萨斯大学医学博士安德森癌症中心质子治疗设施
5. Evaluation of epidemiological and clinical factors in survival of patients with de novo myelodysplastic syndrome at the University of Texas MD Anderson cancer center. [D] . Sunder, Suraj. 2009

机译：德克萨斯大学MD安德森癌症中心评估从头骨髓增生异常综合症患者生存的流行病学和临床因素。
6. Catheter-related Complications and Potential Risk Factors Among Catheterized Cancer Patients Receiving Parenteral Nutrition at The University of Texas MD Anderson Cancer Center: A 26000 Parenteral Nutrition-day Experience [O] . Ruth Reitzel, Anne-Marie Chaftari, Adina Feldman, 2017

机译：德克萨斯大学MD安德森癌症中心的接受肠外营养的导管癌患者中与导管相关的并发症和潜在危险因素：每天26000例肠外营养
7. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-Cell Non-Hodgkin’s lymphoma1,2 1Expert panel members and authors of the review are: Theresa Hahn, PhD, Roswell Park Cancer Institute, Buffalo, NY; Steven N. Wolff, MD, Vanderbilt University, Nashville, TN, Myron Czuczman, MD, Roswell Park Cancer Institute, Buffalo, NY; Richard I. Fisher, MD, Cardinal Bernardin Cancer Center, Loyola University, Chicago, IL; Hillard M. Lazarus, MD, Comprehensive Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH; Philip L. McCarthy, MD, Roswell Park Cancer Institute, Buffalo, NY; Julie Vose, MD, University of Nebraska Medical Center, Omaha, NE; Lisa Warren, Cure for Lymphoma Foundation, New York, NY; and Richard Watt, MD, United Resource Networks, Minneapolis, MN. 2Reference: Hahn T, Wolff SN, Czuczman M, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence-based review. Biol Blood Marrow Transplant. 2001;7:308–331. [O] . 2003

机译：造血干细胞移植的细胞毒性治疗在治疗弥漫性大细胞B细胞非霍奇金淋巴瘤1,2中的作用1，专家小组成员和评价的作者是：纽约州布法罗罗斯威尔公园癌症研究所的特蕾莎·哈恩博士；田纳西州纳什维尔范德比尔特大学医学博士斯蒂芬·沃尔夫（Steven N. Wolff），纽约州布法罗罗斯维尔公园癌症研究所医学博士迈伦·库兹曼（Myron Czuczman）；理查德·费舍尔（Richard I. Fisher）医学博士，伊利诺伊州芝加哥洛约拉大学贝纳尔丁枢机主教癌症中心；俄亥俄州克利夫兰凯斯西储大学克利夫兰大学医院综合癌症中心医学博士Hillard M. Lazarus；纽约州布法罗罗斯韦尔公园癌症研究所医学博士Philip L.内布拉斯加州奥马哈市内布拉斯加大学医学中心医学博士Julie Vose；丽莎·沃伦（Lisa Warren），纽约州纽约市淋巴瘤基金会的治疗；和明尼苏达州明尼阿波利斯市联合资源网络公司的医学博士Richard Watt。 2参考文献：Hahn T，Wolff SN，Czuczman M等。一项基于证据的综述：造血干细胞移植的细胞毒性治疗在弥漫性大细胞B细胞非霍奇金淋巴瘤治疗中的作用。 Biol骨髓移植。 2001; 7：308-331。

Patient Based Validation and Improvement of the Laboratory Based Calibration of the Fast Dose Calculator for Passive Scattering Proton Therapy at The University of Texas MD Anderson Cancer Center

著录项

相似文献

相关主题

期刊订阅